International Journal of Gerontology
Volume 1, Issue 3 , Pages 103-111 , September 2007

Role Of Metalloproteinases in Plaque Rupture

  • Andrew C Newby

      Affiliations

    • Corresponding Author InformationCorrespondence to: Professor Andrew Newby, Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK

,Accepted 30 June 2007.

References 

  1. Nagase H , Visse R , Murphy G . Structure and function of matrix metalloproteinases and TIMPs . Cardiovasc Res . 2006;69:562–573
  2. Dollery CM , Libby P . Atherosclerosis and proteinase activation . Cardiovasc Res . 2006;69:625–635
  3. Shipley JM , Wesselschmidt RL , Kobayashi DK , Ley TJ , Shapiro SD . Metalloelastase is required for macrophagemediated proteolysis and matrix invasion in mice . Proc Natl Acad Sci U S A . 1996;93:3942–3946
  4. Pepper MS . Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis . Arterioscler Thromb Vasc Biol . 2001;21:1104–1107
  5. Virmani R , Burke AP , Farb A , Kolodgie FD . Pathology of the vulnerable plaque . J Am Coll Cardiol . 2006;47:C13–C18
  6. Newby AC . Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates . Cardiovasc Res . 2006;69:614–624
  7. Aguilera CM , George SJ , Johnson JL , Newby AC . Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein . Cardiovasc Res . 2003;58:679–688
  8. Quasnichka H , Slater SC , Beeching CA , Boehm M , SalaNewby GB , George SJ . Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression . Circ Res . 2006;99:1329–1337
  9. Uglow EB , Slater S , Aguilera-Garcia CM , Sala-Newby GB , Angelini GD , Newby AC , et al.   Dismantling of N-cadherin cell-cell contacts modulates smooth muscle proliferation . Circ Res . 2003;92:1314–1321
  10. Bond M , Sala-Newby GB , Newby AC . Focal adhesion kinase (FAK)-dependent regulation of S-phase kinaseassociated protein-2 (Skp-2) stability: a novel mechanism regulating smooth muscle cell proliferation . J Biol Chem . 2004;279:37304–37310
  11. Wu YJ , Bond M , Sala-Newby GB , Newby AC . Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation . Circ Res . 2006;98:1141–1150
  12. Galis ZS , Sukhova GK , Lark MW , Libby P . Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques . J Clin Invest . 1994;94:2493–2503
  13. Galis ZS , Sukhova GK , Libby P . Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue . FASEB J . 1995;9:974–980
  14. Johnson JL , Jackson CL , Angelini GD , George SJ . Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques . Arterioscler Thromb Vasc Biol . 1998;18:1707–1715
  15. Aikawa M , Rabkin E , Okada Y , Voglic SJ , Clinton SK , Brinckerhoff CE , et al.   Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma. A potential mechanism of lesion stabilization . Circulation . 1998;97:2433–2444
  16. Aikawa M , Rabkin E , Sugiyama S , Voglic SJ , Fukumoto Y , Furukawa Y , et al.   An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro . Circulation . 2001;103:276–283
  17. Lijnen HR , Lupu F , Moons L , Carmeliet P , Goulding D , Collen D . Temporal and topographic matrix metalloproteinase expression after vascular injury in mice . Thromb Haemost . 1999;81:799–807
  18. Brown D , Hibbs MS , Kearney M , Loushin C , Isner JM . Identification of 92-kDa gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina . Circulation . 1995;91:2125–2131
  19. Henney AM , Wakeley PR , Davies MJ , Foster K , Hembry R , Murphy G , et al.   Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization . Proc Natl Acad Sci U S A . 1991;88:8154–8158
  20. Nikkari ST , O'Brien KD , Ferguson M , Hatsukami T , Welgus HG , Alpers CE , et al.   Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis . Circulation . 1995;92:1393–1398
  21. Lee RT , Schoen FJ , Loree HM , Lark MW , Libby P . Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture . Arterioscler Thromb Vasc Biol . 1996;16:1070–1073
  22. Halpert I , Sires UI , Roby JD , Potter-Perigo S , Wight TN , Shapiro SD , et al.   Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme . Proc Natl Acad Sci U S A . 1996;93:9748–9753
  23. Herman MP , Sukhova GK , Libby P , Gerdes N , Tang N , Horton DB , et al.   Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling . Circulation . 2001;104:1899–1904
  24. Li Z , Li L , Zielke R , Cheng L , Xiao R , Crow MT , et al.   Increased expression of 72-kd type IV collagenase in human aortic atherosclerotic lesions . Am J Pathol . 1996;148:121–128
  25. Rajavashisth TB , Xu XP , Jovinge S , Meisel S , Xu XO , Chai NN , et al.   Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques. Evidence for activation by proinflammatory mediators . Circulation . 1999;99:3103–3109
  26. Schonbeck U , Mach F , Sukhova GK , Atkinson E , Levesque E , Herman M , et al.   Expression of stromelysin −3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo . J Exp Med . 1999;189:843–853
  27. Sukhova GK , Schonbeck U , Rabkin E , Schoen FJ , Poole AR , Billinghurst RC , et al.   Evidence for increased collagenolysis by interstitial collagenases-1 and −3 in vulnerable human atheromatous plaques . Circulation . 1999;99:2503–2509
  28. Uzui H , Harpf A , Liu M , Doherty TM , Shukla A , Chai NN , et al.   Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines . Circulation . 2002;106:3024–3030
  29. Thomas AC , Sala-Newby GB , Ismail Y , Johnson JL , Pasterkamp G , Newby AC . Genomics of foam cells and nonfoamy macrophages from rabbits identifies arginase-I as a differential regulator of nitric oxide production . Arterioscler Thromb Vasc Biol . 2006;27:571–577
  30. Choudhary S , Higgins CL , Chen IY , Reardon M , Lawrie G , Vick GW , et al.   Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues . Arterioscler Thromb Vasc Biol . 2006;26:2351–2358
  31. Sluijter JPG , Pulskens WPC , Schoneveld AH , Velema E , Strijder CF , Moll F , et al.   Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms . Stroke . 2006;37:235–239
  32. Ye S . Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome . Cardiovasc Res . 2006;69:636–645
  33. Beyzade S , Zhang S , Wong YK , Day INM , Eriksson P , Ye S . Influences of matrix metalloproteinase −3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction . J Am Coll Cardiol . 2003;41:2130–2137
  34. Hirashiki A , Yamada Y , Murase Y , Suzuki Y , Kataoka H , Morimoto Y , et al.   Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors . J Am Coll Cardiol . 2003;42:1429–1437
  35. Ye S , Watts GF , Mandalia S , Humphries SE , Henney AM . Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis . Br Heart J . 1995;73:209–215
  36. Ghilardi G , Biondi ML , DeMonti M , Turri O , Guagnellini E , Scorza R . Matrix metalloproteinase −1 and matrix metalloproteinase −3 gene promoter polymorphisms are associated with carotid artery stenosis . Stroke . 2002;33:2408–2412
  37. Terashima M , Akita H , Kanazawa K , Inoue N , Yamada S , Ito K , et al.   Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction . Circulation . 1999;99:2717–2719
  38. Zhou XY , Huang JF , Chen JH , Su SY , Chen RS , Gu DF . Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population: the Beijing atherosclerosis study . Thromb Haemost . 2004;92:867–873
  39. Flex A , Gaetani E , Papaleo P , Straface G , Proia AS , Pecorini G , et al.   Proinflammatory genetic profiles in subjects with history of ischemic stroke . Stroke . 2004;35:2270–2275
  40. Ye S , Gale CR , Martyn CN . Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease . Eur Heart J . 2003;24:1668–1671
  41. Pearce E , Tregouet DA , Samnegard A , Morgan AR , Cox C , Hamsten A , et al.   Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction . Circ Res . 2005;97:1070–1076
  42. Blankenberg S , Rupprecht HJ , Poirier O , Bickel C , Smieja M , Hafner G , et al.   Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease . Circulation . 2003;107:1579–1585
  43. Zhang B , Ye S , Herrmann SM , Eriksson P , de Maat M , Evans A , et al.   Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis . Circulation . 1999;99:1788–1794
  44. Johnson JL , Carson K , Williams HM , Karanam S , Newby AC , Angelini GD , et al.   Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment . Circulation . 2005;111:1422–1430
  45. Cullen P , Baetta R , Bellosta S , Bernini F , Chinetti G , Cignarella A , et al.   Rupture of the atherosclerotic plaque. Does a good animal model exist? . Arterioscler Thromb Vasc Biol . 2003;23:535–542
  46. Lemaitre V , Soloway PD , D'Armiento J . Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1 . Circulation . 2003;107:333–338
  47. Silence J , Collen D , Lijnen HR . Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene . Circ Res . 2002;90:897–903
  48. Rouis M , Adamy C , Duverger N , Lesnik P , Horellou P , Moreau M , et al.   Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice . Circulation . 1999;100:533–540
  49. Johnson JL , Fritsche-Danielson R , Behrendt M , WestinEriksson A , Wennbo H , Herslof M , et al.   Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability . Cardiovasc Res . 2006;71:586–595
  50. Prescott MF , Sawyer WK , Von Linden-Reed J , Jeune M , Chou M , Caplan SL , et al.   Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury . Ann N Y Acad Sci . 1999;878:179–190
  51. Cherr GS , Motew SJ , Travis JA , Fingerle J , Fisher L , Brandl M , et al.   Metalloproteinase inhibition and the response to angioplasty and stenting in atherosclerotic primates . Arterioscler Thromb Vasc Biol . 2002;22:161–166
  52. Manning MW , Cassis LA , Daugherty A . Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms . Arterioscler Thromb Vasc Biol . 2003;23:483–488
  53. Peterson JT . The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors . Cardiovasc Res . 2006;69:677–687
  54. Fukumoto Y , Deguchi JO , Libby P , Rabkin-Aikawa E , Sakata Y , Chin MT , et al.   Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques . Circulation . 2004;110:1953–1959
  55. Deguchi JO , Aikawa E , Libby P , Vachon JR , Inada M , Krane SM , et al.   Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques . Circulation . 2005;112:2708–2715
  56. Lemaitre V , O'Byrne TK , Borczuk AC , Okada Y , Tall AR , D'Armiento J . ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis . J Clin Invest . 2001;107:1227–1234
  57. Silence J , Lupu F , Collen D , Lijnen HR . Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation . Arterioscler Thromb Vasc Biol . 2001;21:1440–1445
  58. Johnson JL , George SJ , Newby AC , Jackson CL . Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries . Proc Natl Acad Sci U S A . 2005;102:15575–15580
  59. Kuzuya M , Nakamura K , Sasaki T , Cheng XW , Itohara S , Iguchi A . Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice . Arterioscler Thromb Vasc Biol . 2006;26:1120–1125
  60. Luttun A , Lutgens E , Manderveld A , Maris K , Collen D , Carmeliet P , et al.   Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein Edeficient mice against atherosclerotic media destruction but differentially affects plaque growth . Circulation . 2004;109:1408–1414
  61. de Nooijer R , Verkleij CJN , von der Thusen JH , Jukema JW , van der Wall EE , van Berkel TJC , et al.   Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis . Arterioscler Thromb Vasc Biol . 2006;26:340–346
  62. Gough PJ , Gomez IG , Wille PT , Raines EW . Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice . J Clin Invest . 2006;116:59–69
  63. Liang J , Liu E , Yu Y , Kitajima S , Koike T , Jin Y , et al.   Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits . Circulation . 2006;113:1993–2001
  64. Hanemaaijer R , Koolwijk P , le Clercq L , de Vree WJA , van Hinsbergh VWM . Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factorα, interleukin 1 and phorbol ester . Biochem J . 1993;296:803–809
  65. Fabunmi RP , Baker AH , Murray EJ , Booth RFG , Newby AC . Divergent regulation by growth factors and cytokines of 95-kDa and 72-kDa gelatinases and tissue inhibitors of metalloproteinases −1, −2, and −3 in rabbit aortic smooth muscle cells . Biochem J . 1996;315:335–342
  66. Galis ZS , Muszynski M , Sukhova GK , Simon-Morrissey E , Unemori E , Lark MW , et al.   Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion . Circ Res . 1994;75:181–189
  67. Bond M , Chase AJ , Baker AH , Newby AC . Inhibition of transcription factor NF-κ B reduces matrix metalloproteinase −1, −3 and −9 production by vascular smooth muscle cells . Cardiovasc Res . 2001;50:556–565
  68. Chase A , Bond M , Crook MF , Newby AC . Role of nuclear factor-κ B activation in metalloproteinase −1, −3, and −9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo . Arterioscler Thromb Vasc Biol . 2002;22:765–771
  69. Galis ZS , Sukhova GK , Kranzhöfer R , Clark S , Libby P . Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases . Proc Natl Acad Sci U S A . 1995;92:402–406
  70. Mach F , Schonbeck U , Bonnefoy JY , Pober JS , Libby P . Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Induction of collagenase, stromelysin, and tissue factor . Circulation . 1997;96:396–399
  71. Mach F , Schonbeck U , Fabunmi RP , Murphy C , Atkinson E , Bonnefoy JY , et al.   T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L dependent mechanism: implications for tubule formation . Am J Pathol . 1999;154:229–238
  72. Malik N , Greenfield BW , Wahl AF , Kiener PA . Activation of human monocytes through CD40 induces matrix metalloproteinases . J Immunol . 1996;156:3952–3960
  73. Schonbeck U , Mach F , Sukhova GK , Bonnefoy JY , Libby P . CD40 ligation on smooth muscle cells induces expression of matrix metalloproteinases: implication for plaque rupture? . Atherosclerosis . 1997;134:252
  74. Wu M , Li YG . The expression of CD40-CD40L and activities of matrix metalloproteinases in atherosclerotic rats . Mol Cell Biochem . 2006;282:141–146
  75. Wu L , Fan J , Matsumoto S , Watanabe T . Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40 signaling in monocyte/macrophages . Biochem Biophys Res Commun . 2000;269:808–815
  76. Gurjar MV , Deleon J , Sharma RV , Bhalla RC . Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction . Am J Physiol Heart Circ Physiol . 2001;281:H2568–H2574
  77. Kenagy RD , Nikkari ST , Welgus HG , Clowes AW . Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kDa gelatinase, and collagenase) in primate arterial smooth muscle cells . J Clin Invest . 1994;93:1987–1993
  78. Uria JA , Jimenez MG , Balbin M , Freije JMP , LopezOtin C . Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts . J Biol Chem . 1998;273:9769–9777
  79. Fang KC , Wolters PJ , Steinhoff M , Bidgol A , Blount JL , Caughey GH . Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta . J Immunol . 1999;162:5528–5535
  80. Busiek DF , Baragi V , Nehring LC , Parks WC , Welgus HG . Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones . J Immunol . 1995;154:6484–6491
  81. Feinberg MW , Jain MK , Werner F , Sibinga NES , Wiesel P , Wang H , et al.   Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages . J Biol Chem . 2000;275:25766–25773
  82. Corcoran ML , Stetler-Stevenson WG , Brown PD , Wahl LM . Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes . J Biol Chem . 1992;267:515–519
  83. Lacraz S , Nicod LP , Chicheportiche R , Welgus HG , Dayer JM . IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes . J Clin Invest . 1995;96:2304–2310
  84. Schonbeck U , Mach F , Sukhova GK , Murphy C , Bonnefoy JY , Fabunmi RP , et al.   Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? . Circ Res . 1997;81:448–454
  85. Mach F , Schonbeck U , Sukhova GK , Atkinson E , Libby P . Reduction of atherosclerosis in mice by inhibition of CD40 signalling . Nature . 1998;394:200–203
  86. Schonbeck U , Sukhova GK , Shimizu K , Mach F , Libby P . Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice . Proc Natl Acad Sci U S A . 2000;97:7458–7463
  87. Lutgens E , Gorelik L , Daemen MJ , de Muinck ED , Grewal IS , Koteliansky VE , et al.   Requirement for CD154 in the progression of atherosclerosis . Nat Med . 1999;5:1313–1316
  88. Bellosta S , Via D , Canavesi M , Pfister P , Fumagalli R , Paoletti R , et al.   HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages . Arterioscler Thromb Vasc Biol . 1998;18:1671–1678
  89. Crisby M , Nordin-Fredriksson G , Shah PK , Yano J , Zhu J , Nilsson J . Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization . Circulation . 2001;103:926–933
  90. Luan Z , Chase AJ , Newby AC . Statins inhibit secretion of metalloproteinases −1, −2, −3, and −9 from vascular smooth muscle cells and macrophages . Arterioscler Thromb Vasc Biol . 2003;23:769–775
  91. Marx N , Sukhova G , Murphy C , Libby P , Plutzky J . Macrophages in human atheroma contain PPAR gamma: differentiation-dependent peroxisomal proliferatoractivated receptor gamma (PPAR gamma) expression and reduction of MMP-9 activity through PPAR gamma activation in mononuclear phagocytes in vitro . Am J Pathol . 1998;153:17–23
  92. Shu H , Wong BM , Zhou GC , Li Y , Berger J , Woods JW , et al.   Activation of PPAR alpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells . Biochem Biophys Res Commun . 2000;267:345–349
  93. Marx N , Schonbeck U , Lazar MA , Libby P , Plutzky J . Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells . Circ Res . 1998;83:1097–1103

PII: S1873-9598(08)70030-9

doi: 10.1016/S1873-9598(08)70030-9

International Journal of Gerontology
Volume 1, Issue 3 , Pages 103-111 , September 2007

Article Tools